The Qualcomm-backed connected device technology developer has raised $10.5m in a round led by holding company China Merchants Group.

Pfizer and Merck's corporate venturing vehicles have contributed to small-molecule oncology treatment developer Storm Therapeutics' series A round.

GV and Bloomberg have reinvested in the geospatial data technology developer, while CME Group's corporate venturing unit has made its own strategic investment.

The round was led by Monsanto's corporate venturing unit, Monsanto Growth Ventures, and follows a $3m series A two years earlier.

Direct selling company Vorwerk's corporate venturing vehicle made its second investment in Juniqe as part of the affordable art platform's series B round.

Sales communication platform Outreach became the fifth company to receive funding from Microsoft Ventures in the space of a month, raising $17.5m in series B capital.

The medication tracking and kit processing software provider secured funding in a series C round led by Baxter Ventures that included Kaiser Permanente.

Cybersecurity monitoring and testing company NSS took its overall funding to $27m, just over a year after raising cash from backers including Chevron.

Zhubajie led corporate outsourcing services provider 51Shebao's series B round, lifting its overall funding to $14m.

Virtual reality video provider Within has raised series A cash from backers including 21st Century Fox, WME, Live Nation, Vice Media and Legendary Pictures.